Wei-Lin Jin (Weilin Jin)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Signal transduction and targeted therapy

Cancers

Medicina (Kaunas, Lithuania)

MedComm

Shanghai Jiao Tong University

Fourth Military Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Jiao Tong University Dec 01 2005

China

Associate Investigator :: School of science and techology

Education History

Fourth Military Medical University Aug 01 1998 - Jun 22 2004

China

PHD :: Institutes of Neuroscience

Publications

Ying Xia, Ming Sun, Hai Huang, Wei-Lin Jin
Drug repurposing for cancer therapy. Signal transduction and targeted therapy 9 (1) (2024)
Zihe Dong, Yeying Wang, Wei-Lin Jin
Liver cirrhosis: molecular mechanisms and therapeutic interventions. MedComm 5 (10) (2024)
Han-Lin Chen, Wei-Lin Jin
Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Ying Xia, Ming Sun, Hai Huang, Wei-Lin Jin
Drug repurposing for cancer therapy. Signal transduction and targeted therapy 9 (1) (2024)
Ying Xia, Ming Sun, Hai Huang, Wei-Lin Jin
Drug repurposing for cancer therapy. Signal transduction and targeted therapy 9 (1) (2024)
Ying Xia, Ming Sun, Hai Huang, Wei-Lin Jin
Drug repurposing for cancer therapy. Signal transduction and targeted therapy 9 (1) (2024)
Han-Lin Chen, Wei-Lin Jin
Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Han-Lin Chen, Wei-Lin Jin
Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Ying Xia, Ming Sun, Hai Huang, Wei-Lin Jin
Drug repurposing for cancer therapy. Signal transduction and targeted therapy 9 (1) (2024)
Wei-Lin Jin
Midnolin-proteasome pathway for protein degradation. MedComm 4 (6) (2023)
Wen-Ning Li, Shi-Jiao Zhang, Jia-Qing Feng, Wei-Lin Jin
Repurposing Vitamin C for Cancer Treatment: Focus on Targeting the Tumor Microenvironment. Cancers 14 (11) (2022)
Wei Sun, Yongxiang Zou, Zheng Cai, Jinxiang Huang, Xinjie Hong, Qiang Liang, Wei-Lin Jin
Overexpression of NNMT in Glioma Aggravates Tumor Cell Progression: An Emerging Therapeutic Target. Cancers 14 (14) (2022)
Zhaojuan Yang, Guiqin Xu, Boshi Wang, Yun Liu, Li Zhang, Tiantian Jing, Ming Tang, Xiaoli Xu, Kun Jiao, Lvzhu Xiang, Yujie Fu, Daoqiang Tang, Xiaoren Zhang, Wei-Lin Jin, Guanglei Zhuang, Xiaojing Zhao, Yongzhong Liu
USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade. Nature communications 12 (1) (2021)
Wen Jiang, Jin-Wei Hu, Xu-Ran He, Wei-Lin Jin, Xin-Yang He
Statins: a repurposed drug to fight cancer. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Yi-Ke Li, Xiao-Ran Zhu, Yue Zhan, Wen-Zhen Yuan, Wei-Lin Jin
NEK7 promotes gastric cancer progression as a cell proliferation regulator. Cancer cell international 21 (1) (2021)
Guiqin Xu, Zhaojuan Yang, Yizong Ding, Yun Liu, Li Zhang, Boshi Wang, Ming Tang, Tiantian Jing, Kun Jiao, Xiaoli Xu, Zehong Chen, Lvzhu Xiang, Chen Xu, Yujie Fu, Xiaojing Zhao, Wei-Lin Jin, Yongzhong Liu
The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis. Oncogene 40 (36) (2021)
Yigan Zhang, Yuanxue Jing, Yinxue Wang, Jianming Tang, Xiaoran Zhu, Wei-Lin Jin, Yiqing Wang, Wenzhen Yuan, Xiangkai Li, Xun Li
NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal transduction and targeted therapy 6 (1) (2021)
Minfeng Yang, In Young Oh, Arpan Mahanty, Wei-Lin Jin, Jung Sun Yoo
Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives. Cancers 12 (9) (2020)
Ming-Zhu Jin, Wei-Lin Jin
The updated landscape of tumor microenvironment and drug repurposing. Signal transduction and targeted therapy 5 (1) (2020)
Guan-Zhong Qiu, Xiao-Yuan Mao, Yue Ma, Xing-Chun Gao, Zhen Wang, Ming-Zhu Jin, Wei Sun, Yong-Xiang Zou, Jing Lin, Hua-Lin Fu, Wei-Lin Jin
Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization. Cancer science 109 (7) (2018)

Wei-Lin Jin.css-eqlu8i{font-size:small;padding-left:4px;} (Weilin Jin)

Publication Activity (10 Years)

Top Topics

Top Venues

Wei-Lin Jin (Weilin Jin)